Political epidemiology: strengthening socio-political analysis for mass immunisation - lessons from the smallpox and polio programmes.
Control and reduction of infectious diseases is a key to attaining the Millennium Development Goals. An important element of this work is the successful immunisation, especially in resource-poor countries. Mass immunisation, most intensively in the case of eradication, depends on a combination of reliable demand (e.g. public willingness to comply with the vaccine protocol) and effective supply (e.g. robust, generally state-led, vaccine delivery). This balance of compliance and enforceability is, quintessentially, socio-political in nature - conditioned by popular perceptions of disease and risk, wider conditions of economic development and poverty, technical aspects of vaccine delivery, and the prevailing international norms regarding power relations between states and peoples. In the past 100 years, three out of six disease eradication programmes have failed. The explanations for failure have focused on biotechnical and managerial or financial issues. Less attention is paid to socio-political aspects. Yet socio-political explanations are key. Eradication is neither inherently prone to failure, nor necessarily doomed in the case of polio. However, eradication, and similar mass immunisation initiatives, which fail to address social and political realities of intervention may be. A comparison of the smallpox and polio eradication programmes illustrates the importance of disease-specific socio-political analysis in programme conceptualisation, design, and management.
Taylor
S
S
Department of Epidemiology and Public Health, University College London, London, UK. sebastian.taylor@ucl.ac.uk
D003140:Communicable Disease Control / Q000379:methods; D003431:Cross-Cultural Comparison; D003906:Developing Countries; D014943:Global Health; D006291:Health Policy; D054624:Health Status Disparities; D006801:Humans; D007194:India; D007391:International Cooperation; D032541:Mass Vaccination; D009549:Nigeria; D011051:Poliomyelitis / Q000276:immunology / Q000517:prevention & control*; D011055:Poliovirus Vaccine, Oral / Q000008:administration & dosage*; D011057:Politics; D012899:Smallpox / Q000276:immunology / Q000517:prevention & control*; D012900:Smallpox Vaccine / Q000008:administration & dosage*; D012959:Socioeconomic Factors
D011055:Poliovirus Vaccine, Oral; D012900:Smallpox Vaccine